欧洲除颤器市场预测至 2028 年 - COVID-19 影响和按产品(植入式心脏复律除颤器和体外除颤器)和最终用户(医院和诊所、院前护理、公共通道、家庭护理场所和替代护理设施)进行的区域分析

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 198    |    Report Code: TIPRE00025064    |    Category: Life Sciences

Europe Defibrillator Market

欧洲除颤器市场预计将从 2028 年达到

37.0585 亿美元2021年26.9293亿;预计 2021-2028 年复合年增长率为 4.7%。



除颤器是一种用于向心脏输送一定剂量的电流以治疗危及生命的心律失常的医疗设备。这种电流有助于心脏恢复正常、健康的节律。根据治疗所需的类型,除颤器可以是植入式、体外式、经静脉式或皮下式。一些体外除颤器,也称为自动体外除颤器 (AED),经过专门设计,即使未经培训的人员或非专业人士也能使用它们。欧洲除颤器市场的增长归因于心血管疾病(CVD)患病率的增加以及心肺复苏(CPR)和自动体外除颤器(AED)培训和意识计划的增加等因素。然而,产品召回可能会对市场产生负面影响。

 

欧洲除颤器 2028年市场收入及预测(百万美元)


 

市场洞察

心血管疾病患病率不断增加( CVD)

心血管疾病(CVD)可能仍然是全球发病和死亡的最重要原因。根据欧洲心血管疾病统计数据,仅在欧洲,每年就有 180 万人因此死亡,占欧盟所有死亡人数的 36%。根据最近的估计,欧盟有超过 6000 万人患有心血管疾病。此外,CVD 造成的死亡人数超过了癌症造成的死亡人数(欧洲每年有 130 万人;占所有死亡人数的 26%)。此外,根据英国心脏基金会 2021 年情况说明书,英国约有 760 万人患有心脏和循环系统疾病。

因此英国每年因心脏病入院的人数超过 100,000 人,相当于每天 280 人或每五分钟 1 人入院。随着医疗保健系统和基础设施的进步,英国每 10 人中就有 7 人因心脏病发作而幸存,而 20 世纪 60 年代,英国每 10 例心脏病发作中就有超过 7 人死亡。此外,英国有超过 140 万人,其中约 100 万男性和 38 万女性在心脏病发作后幸存下来。因此,心血管疾病和心脏病发病率的上升预计将在预测期内推动欧洲除颤器市场的发展。

 

基于产品洞察

根据产品,欧洲除颤器市场分为植入式心律转复除颤器和体外除颤器。植入式心脏复律除颤器又分为经静脉ICD和皮下ICD。同样,体外除颤器细分为手动、可穿戴和全自动体外除颤器。 2021年,植入式心脏复律除颤器细分市场占据最大市场份额。此外,预计同一细分市场在未来几年还将以最快的速度增长。

 

欧洲除颤器市场(按产品) - 2021 年和 2028 年


 

基于最终用户的见解

根据最终用户,除颤器市场分为医院和诊所、院前护理、公共通道、家庭护理环境和替代护理设施。 2021 年,医院和诊所占据了最大的市场份额。然而,预计院前护理在预测期内的市场复合年增长率最高。

 

战略见解

产品发布和批准是公司扩大全球足迹和产品组合时普遍采用的策略。欧洲除颤器市场的公司注重通过合作战略来扩大客户群,从而使他们能够在全球范围内保持自己的品牌声誉。

 

 

span>

欧洲除颤器市场 –按产品

  • 植入式心脏复律除颤器
    • 经静脉ICD
    • 皮下ICD
  • 外部
    • 手动
    • 全自动体外除颤器
    • 可穿戴式

欧洲除颤器市场 –按最终用户划分

  • 医院和诊所
  • 院前护理
  • < li>公共通道
  • 家庭护理设施
  • 替代护理设施
  • < /ul>

     

    欧洲除颤器市场 –按国家/地区

    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 奥地利< /li>
    • 瑞士
    • 瑞典
    • 挪威
    • 丹麦
    • 荷兰
    • 芬兰
    • 葡萄牙
    • 罗马尼亚
    • 欧洲其他地区

    公司简介

    • 美敦力
    • 雅培
    • 波士顿科学公司
    • 佐尔医疗公司
    • Koninklijke Philips NV
    • Biotronik, INC.
    • CU Medical Systems, INC.
    • Progetti SRL
    • 深圳迈瑞生物医疗电子有限公司
    • 日本光电株式会社


    Europe Defibrillator Strategic Insights

    Strategic insights for Europe Defibrillator involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/europe-defibrillator-market-strategic-framework.webp
    Get more information on this report

    Europe Defibrillator Report Scope

    Report Attribute Details
    Market size in 2021 US$ 2,692.93 Million
    Market Size by 2028 US$ 3,705.85 Million
    Global CAGR (2021 - 2028) 4.7%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 产品
    • 植入式心脏复律除颤器及体外
    By 最终用户
    • 医院和诊所
    • 院前护理
    • 公共场所
    • 家庭护理机构
    • 替代护理机构
    Regions and Countries Covered 欧洲
    • 英国
    • 德国
    • 法国
    • 俄罗斯
    • 意大利
    • 欧洲其他地区
    Market leaders and key company profiles
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Zoll Medical Corporation
  • Koninklijke Philips N.V.
  • Biotronik, INC.
  • CU Medical Systems, INC.
  • Progetti SRL
  • Shenzhen Mindray Bio-Medical Electronics Co., LTD.
  • Nihon Kohden Corporation
  • Get more information on this report

    Europe Defibrillator Regional Insights

    The regional scope of Europe Defibrillator refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-defibrillator-market-geography.webp
    Get more information on this report

The List of Companies - Europe Defibrillator Market

The List of Companies - Europe Defibrillator Market

  1. Medtronic
  2. Abbott
  3. Boston Scientific Corporation
  4. Zoll Medical Corporation
  5. Koninklijke Philips N.V.
  6. Biotronik, INC.
  7. CU Medical Systems, INC.
  8. Progetti SRL
  9. Shenzhen Mindray Bio-Medical Electronics Co., LTD.
  10. Nihon Kohden Corporation

 

Frequently Asked Questions
How big is the Europe Defibrillator Market?

The Europe Defibrillator Market is valued at US$ 2,692.93 Million in 2021, it is projected to reach US$ 3,705.85 Million by 2028.

What is the CAGR for Europe Defibrillator Market by (2021 - 2028)?

As per our report Europe Defibrillator Market, the market size is valued at US$ 2,692.93 Million in 2021, projecting it to reach US$ 3,705.85 Million by 2028. This translates to a CAGR of approximately 4.7% during the forecast period.

What segments are covered in this report?

The Europe Defibrillator Market report typically cover these key segments-

  • 产品 (植入式心脏复律除颤器及体外)
  • 最终用户 (医院和诊所, 院前护理, 公共场所, 家庭护理机构, 替代护理机构)
  • What is the historic period, base year, and forecast period taken for Europe Defibrillator Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Defibrillator Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Defibrillator Market?

    The Europe Defibrillator Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Zoll Medical Corporation
  • Koninklijke Philips N.V.
  • Biotronik, INC.
  • CU Medical Systems, INC.
  • Progetti SRL
  • Shenzhen Mindray Bio-Medical Electronics Co., LTD.
  • Nihon Kohden Corporation
  • Who should buy this report?

    The Europe Defibrillator Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Defibrillator Market value chain can benefit from the information contained in a comprehensive market report.